Malaysia Expands Voluntary eLabeling for Generic OTC Medicines

Malaysia’s Drug Control Authority (DCA) officially announced the voluntary adoption of eLabeling for all generic OTC drugs categorized as non-scheduled poisons. This initiative is part of the nation’s strategy to accelerate digital transparency and sustainability objectives in pharmaceutical labeling practices.

Key highlights include:

  • Regulatory Guidance: The DCA released updated Regulatory guidance and FAQs for manufacturers and distributors, detailing digital access methods, permitted QR code use, and required content structure for e-labels.
  • Digital Transformation: The guidance highlights the integration of electronic labeling with supply chain tracking, promoting public accessibility and environmental sustainability.
  • Implementation Process: Manufacturers may participate in the voluntary program from October 2025 to December 2026. The DCA will monitor adoption rates, gather stakeholder feedback, and plan for mandatory implementation based on outcomes.
     

Consult Now

Source
https://npra.gov.my/index.php/en/informationen/general-information/elabelling.h…
Select Mandate HA
DCA
Select Mandate Function
Regulatory Labeling